Anti-IL-IRI single domain antibodies and therapeutic uses

Details for Australian Patent Application No. 2011200544 (hide)

Owner Domantis Limited

Inventors Fitzgerald, Mary; Drew, Philip D.; Fox, Craig; DeWildt, Ruud M.; Tomlinson, Ian M.; Holmes, Steve

Agent Davies Collison Cave

Pub. Number AU-A-2011200544

Parent 2005311101

Filing date 9 February 2011

Wipo publication date 3 March 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

C07K 16/44 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material not provided for elsewhere

Event Publications

24 February 2011 Complete Application Filed

3 March 2011 Application Open to Public Inspection

  Published as AU-A-2011200544

3 March 2011 Corrigenda

  Complete Applications Filed - Name Index Under the name Domantis Limited, Application No. 2011200544, under INID (54) correct the title to read Anti-IL-IRI single domain antibodies and therapeutic uses

31 March 2011 Corrigenda

  Complete Applications Filed - Name Index Under the name Domantis Limited, Application No. 2011200544, under INID (54) correct the title to read AntiIL-1R1 single domain antibodies and therapeutic uses

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011200545-Air separator for extracorporeal fluid treatment sets

2011200543-Pharmaceutical compsitions